Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

74.0K
Overview
74.0K
CRISPR01:59

CRISPR

50.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.3K
Homologous Recombination02:31

Homologous Recombination

50.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.4K
CRISPR and crRNAs02:53

CRISPR and crRNAs

16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Frontiers in genome editing·2025
Same author

Timely Intervention: Navigating Ethical Challenges in <i>OTOF</i>-Gene Therapy Trials.

Human gene therapy·2025
Same author

Beyond the traditional distinctions of genome editing: evaluating a vulnerability framework.

Frontiers in genome editing·2024
Same author

Catching the next wave? The relationship between UNESCO and developments in genomics.

European journal of human genetics : EJHG·2024
Same author

Genetics and Justice, Non-Ideal Theory and the Role of Patents: The Case of CRISPR-Cas9.

European journal of health law·2023
Same author

The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1).

Journal of perinatology : official journal of the California Perinatal Association·2022

Related Experiment Video

Updated: Jun 19, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

570

Genome Editing Dilemma: Navigating Dual-Use Potential and Charting the Path Forward.

Ana Ruxandra Badea1, Oliver Feeney2

  • 1University of Bucharest, Faculty of Philosophy, Splaiul Independentei 204, 060024, Bucharest, Romania. anaruxandrabadea@gmail.com.

Journal of Bioethical Inquiry
|July 24, 2024
PubMed
Summary
This summary is machine-generated.

Genome editing offers medical benefits but poses security risks. International regulation and oversight are crucial to prevent malicious use of this dual-use technology.

Keywords:
BioethicsCRISPR/Cas9Dual-useGenome editingMilitarySecurity threats

More Related Videos

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.8K
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

13.6K

Related Experiment Videos

Last Updated: Jun 19, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

570
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.8K
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

13.6K

Area of Science:

  • Biotechnology
  • Genomics
  • Bio-security

Background:

  • Genome editing technologies have advanced significantly, increasing accessibility and accuracy.
  • While beneficial for disease treatment and prevention, these technologies present dual-use concerns.

Purpose of the Study:

  • To highlight the potential national and international security threats posed by genome editing.
  • To advocate for an integrated approach to regulate, detect, prevent, and mitigate malicious use.
  • To address the insufficient attention given to dual-use genomic technology in current global frameworks.

Main Methods:

  • Analysis of contemporary genome editing advancements.
  • Drawing parallels with regulatory and security frameworks in the nuclear field.
  • Proposing practical steps for managing genome editing risks.

Main Results:

  • Genome editing, despite its therapeutic potential, poses a conceivable WMD threat.
  • Existing global regulatory frameworks (e.g., 2021 WHO framework) inadequately address future dual-use genomic technology prospects.
  • Specific steps are proposed for national and international security strategies.

Conclusions:

  • Genome editing requires a proactive and integrated security strategy.
  • Enhanced international dialogue, legally binding verification, and technology tracking are essential.
  • Adapting national security and defense strategies to include genome editing threats is necessary.